Background: information on medication use and risk factors among older people residing in retirement villages and their uptake of medication reviews are scant. Objectives: to identify medication use issues and risk factors for medication-related problems among retirement village residents and to evaluate the uptake of government-subsidised Home Medicines Review (HMR) services in this population. Design: cross-sectional, mail survey. Setting: retirement villages in Victoria, Australia. Participants: members of the Residents of Retirement Villages of Victoria residing in retirement villages (2,116, aged 54-100 years). Methods: a questionnaire was developed incorporating validated scales and items to measure medication risk, medication adherence, co-morbidity, disability, information on medication use, health and the uptake of HMR services. Questionnaires were mailed to participants for self-completion and returned using reply-paid envelopes. Results: of the 2,116 respondents (70.7% response rate), 2,006 (94.8%; 95% confidence interval (CI) 93.9-95.7%) reported using prescribed medications. Three or more health conditions were present in 993 (46.9%; 95% CI 44.8-49.0%) respondents. Five or more regular medications were used by 988 (46.7%; 95% CI 44.6-48.8%) respondents. Twelve or more tablets/capsules per day were used by 229 (10.8%; 95% CI 9.5-12.1%) respondents. The use of narrow therapeutic index medications was reported by 264 (12.5%; 95% CI 11.1-13.9%) respondents. Changes to medication regimens in the previous 3 months were reported by 356 (16.8%; 95% CI 15.2-18.4%) respondents. One or more medication-related risk factors were seen in 1,374 (64.9%; 95% CI 62.9-66.9%) respondents. Of these at-risk residents, 76 (5.5%; 95% CI 4.5-6.5%) reported receiving an HMR in the previous 12 months, who were older (P < 0.001), were using more medicines (P < 0.001) and had greater disability (P = 0.002). Conclusions: reasons for the low uptake of medication reviews in retirement village residents despite the high prevalence of medication risk require further investigation.
Introduction
Retirement villages (similar to sheltered housing in the United Kingdom) provide accommodation for older people who wish to live independently or with limited assistance within a supportive community [1] . Approximately 80,000 Australians reside in retirement villages, and this figure is projected to increase to 300,000 by 2051 [1] .
Research on medication use in older Australians living in retirement villages is scant, but a range of medication-related issues and risk factors have been reported in similar populations in the United Kingdom and the United States [2] [3] [4] . Multiple chronic health problems, polypharmacy and physiological changes that occur with ageing put many older people at increased risk of adverse medication outcomes [5] . In the only published study of medication use in an Australian re-tirement village population, 41% of residents were using multiple medications, including combinations that could potentially cause drug interactions [6] . However, this study involved only a single retirement village and was conducted nearly 20 years ago. Further research is warranted to explore the nature and extent of medication risk factors among retirement village residents in Australia.
Regular review of medications is part of a quality use of medicines strategy to reduce medication misadventure among people who are at risk [7, 8] . The UK Quality and Outcomes Framework currently includes Medicine Use Reviews (MUR) as part of the primary care framework that aims to optimise medication use and health outcomes for individual patients [8] . In Australia, Home Medicines Review (HMR) is a similar medication management review service that aims to maximise individual patient's benefit from their medication regimen and prevent medication-related problems [7] . HMRs are provided to patients in the community setting. A general practitioner (GP) can initiate an HMR for an at-risk patient by making a referral to an accredited pharmacist to conduct the HMR [9] . There is no charge to the patient, and both the GP and pharmacist are reimbursed by the government for delivering the medication review service [9, 10] . The steps that are involved in a single HMR process are summarised in Figure 1 [11]. Uptake of HMRs in the general Australian population has been low -approximately 10% of the eligible general population receive them [12] ; the uptake of HMRs in the retirement village population is unknown.
The purpose of this study was to investigate medication use issues and risk factors for medication-related problems among retirement village residents and to assess the uptake of HMRs in this population.
Methods
A cross-sectional survey of retirement village residents in Victoria, Australia was conducted between November 2008 and January 2009. A four-page, 29-item questionnaire was developed including items on demographics, general health, use of health services, use of medications associated with increased risk of adverse events or drug-related hospitalisations in older people [13] [14] [15] , and validated scales for measuring comorbidity (Charlson co-morbidity index) [16] , disability (Townsend scale) [17] , medication adherence (Morisky scale) [18] and medication risk [Medication Risk Questionnaire (MRQ)] [19] . The Charlson co-morbidity index gives a total co-morbidity score which predicts the mortality rate for a patient who has a range of health conditions, with each health condition scored differently (0, 1, 2, 3 or 6) based on its effect on mortality [16] . A total score of five or more on the Charlson co-morbidity index represents high risk of mortality [16] . The total disability score on the Townsend scale ranges between 0 and 18, with a higher score representing a greater degree of physical disability [17] . The total score on the Morisky scale ranges between 0 and 4, and a score of less than 4 represents nonadherence [18] . Medication risk was assessed using five items of the MRQ that have been consistently associated with an increased risk of adverse medication events [3, 19] . Face and content validity of the questionnaire were reviewed and established by a panel of academics and practising pharmacists (n = 7). The questionnaire was pilot tested in a sample of five older people.
The self-completed anonymous questionnaire, plain language statement and reply-paid envelope were sent to all members (n = 2,442) of the Residents of Retirement Villages of Victoria (RRVV), along with the RRVV newsletter. RRVV is an organisation representing the needs and interests of residents of retirement villages in Victoria; approximately 10% of retirement village residents in Victoria are members of the RRVV. Additional copies of the questionnaire (n = 568) were sent to addresses having two residents according to the RRVV database, giving a total of 3,010 questionnaires. A reminder was sent with the next issue of the newsletter to all RRVV members 6 weeks after the initial mail out. The cut-off date for survey responses was set at 14 weeks after the initial mail out.
The study was approved by the Monash University Standing Committee on Ethics in Research involving Humans.
Statistical analysis
Responses were analysed using Statistical Package for the Social Sciences (SPSS), version 15.0 (SPSS Inc., Chicago). Categorical variables are presented as frequencies and proportions and continuous variables as means and standard deviation, or medians and range for skewed data. Data are reported with 95% confidence intervals (CI), where relevant.
Univariate analysis was performed to compare characteristics of the HMR vs non-HMR subjects. Student's t-test was used for normally distributed continuous variables, Mann-Whitney test for non-normally distributed continuous variables and Chi-square test for categorical variables; P-value < 0.05 was considered statistically significant. The Patient visits GP ↓ GP offers HMR to patient and makes referral to patient's preferred community pharmacy ↓ Community pharmacy contacts accredited pharmacist (may be an employee of the pharmacy or external contractor) ↓ Accredited pharmacist contacts patient and visits them at their home to review and discuss medication management ↓ Accredited pharmacist writes a report and forwards copies to GP and community pharmacy ↓ Patient returns to visit GP ↓ GP discusses HMR findings with patient and prepares a medication management plan ↓ GP forwards copy of medication management plan to community pharmacy retirement village population in Victoria is estimated to be 25,000 [20] . A minimum of 268 responses was required for each item in the questionnaire to provide data with 90% confidence level and 5% margin of error.
Results
Responses were received from 2,140 residents; 15 questionnaires were returned to the researchers due to residents having moved or being deceased; 855 questionnaires were not returned at all. Twenty-four questionnaires were incomplete and were excluded, leaving 2,116 (70.7%) questionnaires included in the analysis. Demographic details and medication use features of the sample are shown in Table 1 . The mean age of respondents was 78.6 (SD 6.7) years (range 54-100 years), and 1,253 (59.2%) were females. In the previous 3 months, 1,910 (90.3%; 95% CI 89.0-91.6%) respondents visited their GP and/or specialist at least once. The median number of GP and/or specialist visits was 2 (range 0-30). In the previous 12 months, 435 (20.6%; 95% CI 18.9-22.3%) respondents self-reported having one or more unplanned hospitalisations. Sixty-eight (3.2%; 95% CI 2.5-4.0%) respondents scored 5 or more on the Charlson co-morbidity index (median score 1, range 0-8) and hence had a high risk of mortality. Two hundred and seven (9.8%; 95% CI 8.5-11.1%) respondents scored 7 or more on the Townsend disability scale, indicating appreciable to very severe disability (median score 1, range 0-18).
The use of prescribed medication(s) was reported by 2,006 (94.8%; 95% CI 93.9-95.8%) respondents. The median number of prescribed medications taken on a regular basis was 4 (range 0-20); and on an 'as-needed' basis was 1 (range 0-13). The use of non-prescribed medication(s) was reported by 1,203 (56.9%; 95% CI 54.8-59.0%) respondents. There were 199 (9.4%; 95% CI 8.2-10.6%) respondents who reported experiencing an adverse drug reaction (ADR) from their medication(s) at the time of the study. Moreover, 1,884 (89.0%; 95% CI 87.7-90.3%) respondents reported taking at least one medication known to be associated with an increased risk of adverse events or drug-related hospitalisations in the elderly ( ) of these at-risk respondents reported having regular visits to doctors or specialists in the previous 3 months, only 76 (5.5%; 95% CI 4.5-6.5%) reported receiving an HMR in the previous 12 months. Only 12 (6.0%; 95% CI 5.0-7.0%) of the 199 respondents who reported experiencing an ADR at the time of the study reported receiving an HMR.
In univariate analysis, the characteristics of at-risk residents who had received HMRs (n = 76) were compared with those of their counterparts (n = 1,288) ( Table 3 ). There were significant differences in the following factors between the HMR vs non-HMR subjects: age (P < 0.001), number of prescribed medications taken on a regular basis (P < 0.001), self-collecting medications from the pharmacy (P < 0.001), disability scores (P = 0.002), use of one or more strategies to help remember taking medications (P = 0.003), seeing one or more doctors/specialists to obtain prescriptions (P = 0.005), use of non-solid and oral dose forms (P = 0.006), times seen by doctor/specialist in the previous 3 months (P = 0.008), have had a pharmacist speak with them about current medications (P = 0.012) and number of medicationrelated risk factors (P = 0.035). Multivariate analysis was not possible due to the small number of subjects in the HMR group.
Discussion
This is the first large scale study on medication use, medication risk and the uptake of medication review services among Australian retirement village residents. A high prevalence of medication-related risk factors, but a very low uptake of medication review services was identified in this group. Nearly two-thirds of respondents reported one or more risk factors for adverse medication events, and one in ten reported that they were experiencing an ADR at the time of the survey; however, about one in twenty of these at-risk residents had received a pharmacist-conducted HMR in the previous 12 months. At-risk residents who had a pharmacist-conducted HMR were older, frailer and sicker than their counterparts with medication-related risk factors.
There is evidence that the use of five or more medications (polypharmacy), 12 or more medication doses per day, medications with narrow therapeutic index, medication regimen changes, presence of three or more concurrent disease states (multiple co-morbidities) and having scores of five or greater on the Charlson co-morbidity index are associated with an increased risk of adverse medication outcomes and hospital admissions among older adults [3, 5, 15, 19] . The extent of self-reported ADRs in this study is consistent with that reported in the literature [21] . The use of cardiovascular medications, antiplatelet agents, non-steroidal anti-inflammatory drugs, opioid analgesics, hypnotics, antidepressants, anticoagulants, corticosteroids, oral hypoglycaemics, psychotropic agents, antiparkinsonian agents and anticonvulsants is associated with an increased risk of ADRs resulting in hospitalisations among older adults [5, 13, 22] . ADRs have been reported to cause 10 to 20% of unplanned hospital admissions in the elderly [5] . Nonadherence has been identified as a common cause of therapeutic failure leading to hospitalisations [23] . The association between disability and unplanned hospitalisation is also well established [3] . The majority of respondents in this study had one or more of these risk factors for adverse outcomes.
A multidisciplinary service model involving GPs and pharmacists delivering medication reviews to patients at risk of medication misadventure in the Australian community has been shown to have positive trends in clinical outcomes and costs [24] . A recent study demonstrated that HMRs resulted in a 45% reduction in the rate of hospitalisation for heart failure among the veterans who had received an HMR [25] . Pharmacist-conducted home-based medication reviews in older adults in the United Kingdom have been shown to result in improved patient knowledge and medication adherence [26] . Medication reviews performed by pharmacists for at-risk older adults in the United Kingdom and Australian primary care settings have resulted in identification and resolution of a significant number of medication-related problems [27, 28] . Such a collaborative medication review service model may have substantial effects on medication misadventure risk reduction and patient care [24, 25, 27, 29] .
The UK National Prescribing Centre and National Service Framework for Older People recommend targeting older people or those who are at risk of adverse medication outcomes for MUR and require an annual review in those over 75 years [8, 30] . Similarly, the Australian Pharmaceutical Advisory Council recommends targeting those who are at risk of adverse medication outcomes for HMR [7] . The National Prescribing Service recommends an annual medication review as part of the annual health assessment for older people [29] .
The five-item MRQ used to assess medication risk in our study closely resembles the UK MUR criteria [8] , and the HMR eligibility criteria that are used by Australian GPs to identify people at risk of medication-related problems in order to make an HMR referral [7] ; therefore, the majority of respondents in our study would qualify for an HMR. However, the uptake of HMRs was low despite the majority of respondents having regular visits to their doctors. Reasons for underutilisation of HMR services could include GP's lack of belief in the benefits of pharmacist-conducted HMRs, especially when evidence for the benefits of pharmacist medication review is inconclusive [11] . Workforce and/ or workload issues for GPs and poor awareness among the general public about the HMR service might also have contributed to the low uptake [11] .
Our study has some strengths and limitations. The high response rate and large sample size suggest that our findings could be generalised to all retirement village residents and people living in similar settings; however, only RRVV members were included in the study, because RRVV was the only organisation that had a database of retirement village resi- Things help to remember taking medications -Webster/blister pack or dosette/pill box, medication list/reminder chart, alarm/beeper and calendar/diary. i Difficulties with using medications -opening containers, using puffers or patches, getting to doctor/pharmacy when medicines run out, understanding different brands of medicines, reading and understanding labels, remembering doses and swallowing medicines. dents at the time of study. It may be that RRVV members are likely to represent a highly motivated group of retirement village residents. In addition, the fact that very few residents from assisted living units responded makes the results less relevant to people in assisted living units; however, residents in assisted living units tend to be older, have poorer health and take more medications [6, 31] . Hence, the extent of medication risk observed is likely to be an underestimation. The demographic characteristics of our study participants were similar to those of retirement village residents in general [6, 31] , but it is possible that RRVV members had different socioeconomic features, such as education and income compared to their non-member counterparts, but those measures were not included in our questionnaire. Lastly, we relied on resident self-report and we cannot confirm its accuracy.
Our findings suggest that the screening of medication-related risk factors in retirement village residents requires improvement. Interventions for increasing the uptake of medication review services in retirement villages should also be explored. A simpler and more efficient screening/referral process for HMR using the expertise of trained non-medical professionals or pharmacist-initiated medication reviews (similar to the process that currently exists in Australian nursing homes) are possible solutions. Future studies should develop and test such screening programmes and interventions.
Conclusions
The majority of residents in retirement villages were potentially at risk of medication misadventure. Despite the high prevalence of medication-related risk factors, relatively few residents had received a government-subsidised HMR in the previous 12 months. The reasons for the current poor uptake of HMRs in this group, and strategies for increasing uptake, require further investigation.
Key points
• Older people are at increased risk of adverse medication outcomes.
• Data on medication use and risk factors among older people residing in retirement villages and their uptake of medication reviews are scant.
• In this study, two-thirds of retirement village residents had at least one risk factor for adverse medication events, but less than 10% had received a medication review service.
• The poor uptake of medication reviews in older people requires further investigation.
